Two Sigma Advisers
CORV

Two Sigma Advisers’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Two Sigma Advisers’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-230,900
Closed -$90K – 2659
2020
Q1 		$90K Buy
230,900
+34,800
+18% +$12.6K ﹤0.01% 2310
2019
Q4 		$80K Buy
+196,100
New +$326K ﹤0.01% 2269

Two Sigma Advisers's CORV Position: Q2 2020 in Review

Two Sigma Advisers sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2020, closing a stake of 230,900 shares — an estimated $90K sold.

Two Sigma Advisers first reported a position in CORV in Q4 2019 and held it in 2 quarters. The position peaked at $90K in Q1 2020. 0 funds tracked by Wall St. Rank hold CORV as of Q2 2020.

  • Two Sigma Advisers reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2020 after selling out during the quarter.
  • Two Sigma Advisers sold 230,900 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2020, an estimated $90K.
  • Two Sigma Advisers first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q4 2019 and held it in 2 quarters.
  • Two Sigma Advisers's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $90K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2020.

Based on Two Sigma Advisers's 13F filing for Q2 2020, filed 14 Aug 2020.